Napasawan Chumnanveja,
Natthapol Samakkanada,
Manat Pohmakotra,
Vichai Reutrakula,
Thaworn Jaipetchb,
Darunee Soorukrama and
Chutima Kuhakarn*a
aDepartment of Chemistry and Center of Excellence for Innovation in Chemistry (PERCH-CIC), Faculty of Science, Mahidol University, Rama VI Road, Bangkok 10400, Thailand
bMahidol University, Kanchanaburi Campus, Saiyok, Kanchanaburi 71150, Thailand
First published on 28th October 2014
A novel OXONE® mediated direct difunctionalization of alkenes with NaNO2 in aqueous acetonitrile for the synthesis of α-nitrooximes was developed. The α-nitrooximes were readily prepared in moderate to high yields at room temperature under mild reaction conditions. The present protocol offers an easy and environmentally benign approach to access various α-nitrooximes derived from styrene derivatives.
In contrast to the synthesis of oximes from alkenes,7 the synthesis of α-nitrooximes has been less studied (Scheme 1).8 Scheinbaum employed the reaction of olefins with nitrous anhydride (N2O3) generated by the reaction of nitric oxide and air, followed by the treatment of the initially obtained pseudonitrosites with ZnCl2 (Scheme 1, Path A).8c The preformed peroxynitrite-promoted reaction of styrene, leading to a mixture of α-nitrooxime, nitrate, benzaldehyde, α-nitroacetophenone and a nitroalkene was reported by Grossi (Scheme 1, Path B).8b Also, a solvent-free synthesis of pseudonitrosites, which can undergo tautomerization to α-nitrooxime, was reported by Shaabani and co-workers (Scheme 1, Path C).8a Despite significant developments, available methods toward α-nitrooxime synthesis required gaseous reagents or tedious experimentations for the preparation of the requisite reagent.8c,9 With continuous research efforts aiming at 1,2-difunctionalizations of alkenes and alkynes,10 we report herein an alternative, convenient and efficient synthesis of α-nitrooximes from alkenes by employing commercially available reagents (NaNO2 and OXONE®) (Scheme 1). OXONE® is found in many synthetic applications, due to its stability, high efficiency and mild reaction conditions, as well as the minimization of organic chemical waste.11
| Entry | OXONE® | NaNO2 | Solvent | Yieldb (%) | |
|---|---|---|---|---|---|
| (equiv.) | (equiv.) | (v/v) | 2ac | 3a | |
| a Reaction conditions: 1a (0.5 mmol), NaNO2 (half of the total amount employed), and OXONE® were suspended in an organic solvent, followed by the slow addition of water. After the reaction was stirred at room temperature for 45 min, a second half portion of NaNO2 was added and the reaction was further stirred for an additional 45 min.b Isolated yield.c In all cases, 2a was obtained as a single isomer after chromatographic purification. | |||||
| 1 | 2 | 4 | CH2Cl2 : H2O (1 : 2) |
37 | 8 |
| 2 | 2 | 4 | ClCH2CH2Cl : H2O (1 : 2) |
40 | 19 |
| 3 | 2 | 4 | EtOAc : H2O (1 : 2) |
52 | 7 |
| 4 | 2 | 4 | Acetone : H2O (1 : 2) |
55 | 10 |
| 5 | 2 | 4 | Toluene : H2O (1 : 2) |
43 | 13 |
| 6 | 2 | 4 | iPrOH : H2O (1 : 2) |
22 | — |
| 7 | 2 | 4 | MeOH : H2O (1 : 2) |
— | — |
| 8 | 2 | 4 | CH3CN : H2O (1 : 2) |
84 | 6 |
| 9 | 2 | 4 | CH3CN : H2O (2 : 1) |
68 | 5 |
| 10 | 2 | 2 | CH3CN : H2O (1 : 2) |
9 | 10 |
| 11 | 2 | 3 | CH3CN : H2O (1 : 2) |
44 | 2 |
| 12 | 1 | 4 | CH3CN : H2O (1 : 2) |
47 | 19 |
| 13 | 4 | 4 | CH3CN : H2O (1 : 2) |
45 | 13 |
With the above optimal reaction conditions in hand (Table 1, entry 8), the scope and limitations of the reaction were evaluated by employing a range of structurally different styrene derivatives. It should be noted that, except for 2r, the α-nitrooximes were obtained as a mixture of two isomers (1H NMR analysis of the crude mixtures or after chromatographic purification). Upon column chromatographic purification, in some cases, the α-nitrooximes were isolated as a single isomer. The results are summarized in Table 2. Halogen-substituted styrene derivatives including Br, Cl and F at the para-, meta-, or ortho-positions gave the corresponding products in moderate to good yields (59–84% yields) (Table 2, entries 1–6). Furthermore, 4-nitrostyrene and 3-nitrostyrene also gave moderate yields (62–66% yields) (Table 2, entries 7 and 8). A sensitive formyl group and a chloromethyl group were found to be well accommodated and each of their corresponding products were obtained as a single isomer (Table 2, entries 9 and 10). Electron-releasing substituted styrenes including 4-Me-, 4-MeO-, and 4-tBu-substituted styrenes appeared less efficient, yielding the corresponding α-nitrooximes in moderate yields (45–59% yields) (Table 2, entries 11–13). 4-Acetoxystyrene afforded its corresponding α-nitrooxime in 71% yield (Table 2, entry 14). Moreover, the reactions involving a simple styrene, 1-vinylnaphthalene, and β-substituted styrene derivatives which include β-methylstyrene and 1,2-dihydronaphthalene, were also successful, yielding the respective products in moderate yields (44–63% yields) (Table 2, entries 15–18). Finally, 2-vinylthiophene gave the corresponding α-nitrooxime derivative in 73% yield (Table 2, entry 19) while 2-vinyl- and 4-vinylpyridines led to unidentified complex mixtures. It should be noted that in all cases, the corresponding nitroalkenes (E isomers) were also obtained in varying quantities (2–21% yields). Unfortunately, the present protocol was found to be incompatible with aliphatic alkenes including 1-octene and cyclohexene; complex mixtures were observed in the TLC analyses with poor mass recovery.
| Entry | Substrate | Product; yieldb (%) | ||
|---|---|---|---|---|
| Ar = | R = | α-Nitrooxime, 2 (isomer ratio)c | Nitroalkene, 3 | |
a Reaction conditions: 1 (0.5 mmol), NaNO2 (2 equiv.) and OXONE® (2 equiv.) were suspended in CH3CN (1 mL), followed by the slow addition of water (2 mL). After the reaction was stirred at room temperature for 45 min, NaNO2 (2 equiv.) was added and the reaction was further stirred for an additional 45 min.b Isolated yield; in most cases their corresponding nitroalkenes (E isomers) were isolated in the range of 2–21% yields.c The isomeric ratio was determined by 1H NMR analysis.d 1H NMR spectral data of the crude mixtures exhibited a mixture of two isomers; compound (isomer ratio): 2a (11.0 : 1); 2i (10.5 : 1); 2j (10 : 1); 2l (9.2 : 1); 2o (9.9 : 1).e A 1H NMR spectrum of the crude mixture exhibited a single isomer. |
||||
| 1 | 4-BrC6H4 | H | 2a; 84 (single isomer)d | 3a; 6 |
| 2 | 4-ClC6H4 | H | 2b; 73 (27.6 : 1) |
3b; 10 |
| 3 | 3-ClC6H4 | H | 2c; 74 (14.4 : 1) |
3c; 3 |
| 4 | 2-ClC6H4 | H | 2d; 59 (1.7 : 1) |
3d; 6 |
| 5 | 4-FC6H4 | H | 2e; 69 (11.5 : 1) |
3e; 7 |
| 6 | 3-FC6H4 | H | 2f; 75 (32.3 : 1) |
3f; 2 |
| 7 | 4-O2NC6H4 | H | 2g; 66 (19.0 : 1) |
3g; 5 |
| 8 | 3-O2NC6H4 | H | 2h; 62 (21.2 : 1) |
3h; 3 |
| 9 | 3-OHCC6H4 | H | 2i; 56 (single isomer)d | 3i; 7 |
| 10 | 4-(ClCH2)C6H4 | H | 2j; 60 (single isomer)d | 3j; 7 |
| 11 | 4-MeC6H4 | H | 2k; 45 (10.8 : 1) |
3k; 21 |
| 12 | 4-MeOC6H4 | H | 2l; 51 (single isomer)d | 3l; 5 |
| 13 | 4-tBuC6H4 | H | 2m; 59 (5.5 : 1) |
3m; 8 |
| 14 | 4-AcOC6H4 | H | 2n; 71 (14.4 : 1) |
3n; 9 |
| 15 | C6H5 | H | 2o; 63 (single isomer)d | 3o; 5 |
| 16 | 1-Naphthyl | H | 2p; 44 (1.7 : 1) |
3p; 15 |
| 17 | C6H5 | CH3 | 2q; 52 (2.3 : 1) |
3q; 12 |
| 18 | ![]() |
2r; 56 (single isomer)e | 3r; 0 | |
| 19 | 1-Thienyl | H | 2s; 73 (1 : 1) |
3s; 0 |
While no detailed mechanistic studies were carried out, to follow the reaction pathway, some control experiments were conducted. Thus, the reaction with p-bromostyrene (1a) was carried out in the presence of radical inhibitors, including TEMPO [(2,2,6,6-tetramethylpiperidin-1-yl)oxyl, 1 equiv.] and BHT (3,5-di-tert-butyl-4-hydroxytoluene, 1 equiv.) (Scheme 2). It was found that the α-nitrooxime 2a was obtained in much lower yields, 19% yield and 32% yield, respectively. Since both the TEMPO and BHT experiments only lower the reaction yields rather than cease the reaction, the control experiments do not fully indicate a radical mechanism. On the basis of previous reports,8b,c a mechanistic proposal is predicted as shown in Scheme 3. Primarily, a nitrite anion is oxidized by OXONE®, generating unstable peroxynitrous acid (HPN, HOONO). Under the reaction conditions (OXONE®, pKa ∼ 2), the peroxynitrous acid decomposes, leading to a reactive species which is believed to be nitrous anhydride (N2O3). Alternatively, sodium nitrite under relatively acidic conditions in situ generates nitrous acid (HNO2) which undergoes decomposition to furnish several electrophilic species including NO, NO2, N2O3 and N2O4. The nitrous anhydride reacts with styrene and its derivatives to generate a more stable benzylic radical A and nitric oxide (NO). Subsequent coupling of the benzylic radical A with nitric oxide then gives a C-nitroso derivative which easily undergoes tautomerization, leading to the observed α-nitrooxime 2. It is believed that the major isomer of α-nitrooxime 2 that was obtained has a Z configuration (the methylnitro group syn to the hydroxy group). In comparison with a closely related system, the 1H NMR signals of the methylene protons of the Z isomer resonate at a lower field than those of the E isomer due to the deshielding effect of the electronegative oxygen atom.12 As the corresponding nitroalkene 3 was isolated as a by-product, it is likely to be derived from the benzylic radical A generating a benzyl cation via a one-electron oxidation with OXONE® followed by a deprotonation process. Although the radical mechanistic pathway shown in Scheme 3 can direct alkenes to α-nitrooximes, we cannot exclude the possibility of the ionic mechanism proceeding via the nitronium ion (+NO2) which acts as a nitrating species. The failure of aliphatic alkenes to undergo the reaction suggests the involvement of the cationic intermediate. The formation of nitroalkene 3 also suggests the involvement of the nitronium ion (+NO2) to serve as a reactive electrophile. Thus, the nitronium ion reacts with the styrene substrates, leading to a benzylic cation B which upon elimination of a proton yields nitroalkene 3 (Scheme 3).
N), 1558 and 1375 (NO2) cm−1; MS m/z (%) relative intensity 258 (M+, 55), 181 (57), 169 (100), 102 (59), 89 (73); HRMS (APCI-TOF) calcd for C8H8BrN2O3 [M + H]+ 258.9718, found 258.9719.
:
1, minor isomer marked*) δ 9.87 (br s, 1H of major and minor isomers), 7.54 (dd, J = 6.8, 2.0 Hz, 2H of major and minor isomers), 7.38 (dd, J = 6.8, 2.0 Hz, 2H of major and minor isomers), 5.62 (s, 1.93H), 5.40* (s, 0.07H) ppm. 13C NMR (100 MHz; CDCl3) δ 147.4 (C), 136.4 (C), 131.4 (C), 129.7* (2 × CH), 129.2 (2 × CH), 128.9* (2 × CH), 127.3 (2 × CH), 77.8* (CH2), 68.1 (CH2) ppm (some peaks of the minor isomer could not be detected by 13C NMR due to their low intensity); IR (KBr) ν 3235 (O–H), 1596 (C
N), 1562 and 1379 (NO2) cm−1; HRMS (APCI-TOF) m/z calcd for C8H8ClN2O3 [M + H]+ 215.0223, found 215.0213.
:
1, minor isomer marked*) δ 9.39 (br s, 1H of major and minor isomers), 7.63 (t, J = 1.8 Hz, 0.94H), 7.60* (t, J = 1.8 Hz, 0.06H), 7.49–7.34 (m, 3H of major and minor isomers), 5.62 (s, 1.87H), 5.39* (s, 0.13H) ppm. 13C NMR (100 MHz; CDCl3) δ 147.6 (C), 135.1 (C), 134.7 (C), 130.5 (CH), 130.3 (CH), 130.0* (CH), 128.5* (CH), 126.3 (CH), 126.2* (CH), 124.5* (CH), 124.3 (CH), 77.8* (CH2), 68.2 (CH2) ppm (some peaks of the minor isomer could not be detected by 13C NMR due to their low intensity); IR (KBr) ν 3274 (O–H), 1630 (C
N), 1559 and 1373 (NO2) cm−1; MS m/z (%) relative intensity 214 (M+, 6), 137 (100), 125 (68), 102 (64), 75 (40); HRMS (APCI-TOF) calcd for C8H7ClN2NaO3 [M + Na]+ 237.0043, found 237.0041.
:
1, minor isomer marked*) δ 9.71 (br s, 0.63H), 9.02* (br s, 0.37H), 7.53–7.33 (m, 4H of major and minor isomers), 5.60 (s, 1.25H), 5.42* (s, 0.75H) ppm. 13C NMR (100 MHz; CDCl3) δ 148.8 (C), 147.9* (C), 132.6* (C), 132.5 (C), 131.7 (CH), 131.5 (CH), 131.3 (C), 131.2* (CH), 130.6* (CH), 130.0 (CH), 129.8* (CH), 129.7* (C), 127.5 (CH), 127.0* (CH), 77.4* (CH2), 70.2 (CH2) ppm; IR (neat) ν 3272 (O–H), 1622 (C
N), 1558 and 1373 (NO2) cm−1; MS m/z (%) relative intensity 215 (M+ + 1, 100), 137 (31), 102 (41), 75 (19); HRMS (APCI-TOF) calcd for C8H7ClN2NaO3 [M + Na]+ 237.0043, found 237.0042.
:
1, minor isomer marked*) δ 9.57 (br s, 1H of major and minor isomers), 7.62–7.58 (m, 2H of major and minor isomers), 7.15–7.09 (m, 2H of major and minor isomers), 5.63 (s, 1.84H), 5.40* (s, 0.16H) ppm. 13C NMR (100 MHz; CDCl3) δ 164.0 (d, J = 249.9 Hz, C), 147.7 (d, J = 8.2 Hz, C), 130.6* (d, J = 8.5 Hz, 2 × CH), 129.1 (d, J = 3.1 Hz, C), 128.3 (d, J = 8.5 Hz, 2 × CH), 116.2 (d, J = 21.8 Hz, 2 × CH), 115.9* (d, J = 21.8 Hz, 2 × CH), 78.0* (CH2), 68.5 (CH2) ppm (some peaks of the minor isomer could not be detected by 13C NMR due to their low intensity); IR (KBr) ν 3279 (O–H), 1602 (C
N), 1549 and 1376 (NO2) cm−1; HRMS (APCI-TOF) m/z calcd for C8H7FN2NaO3 [M + Na]+ 221.0338, found 221.0337.
:
1, minor isomer marked*) δ 8.71 (br s, 1H of major and minor isomers), 7.45–7.38 (m, 3H of major and minor isomers), 7.18–7.13 (m, 1H of major and minor isomers), 5.64 (s, 1.94H), 5.40* (s, 0.06H) ppm. 13C NMR (100 MHz; CDCl3) δ 163.0 (d, J = 245.8 Hz, C), 147.5 (d, J = 2.6 Hz, C), 135.1 (d, J = 7.9 Hz, C), 130.7 (d, J = 8.2 Hz, CH), 121.8 (d, J = 2.9 Hz, CH), 117.4 (d, J = 21.2 Hz, CH), 113.2 (d, J = 23.5 Hz, CH), 77.9* (CH2), 68.0 (CH2) ppm (some peaks of the minor isomer could not be detected by 13C NMR due to their low intensity); IR (KBr) ν 3274 (O–H), 1610 (C
N), 1558 and 1376 (NO2) cm−1; MS m/z (%) relative intensity 199 (M+ + 1, 100), 198 (M+, 31), 180 (3), 121 (82), 109 (59); HRMS (APCI-TOF) calcd for C8H7FN2NaO3 [M + Na]+ 221.0338, found 221.0331.
:
1, minor isomer marked*) δ 11.99 (s, 1H of major and minor isomers), 8.23 (dd, J = 7.1, 2.0 Hz, 2H of major and minor isomers), 7.99 (dd, J = 7.1, 2.0 Hz, 2H of major and minor isomers), 5.89 (s, 1.90H), 5.68* (s, 0.10H) ppm. 13C NMR (100 MHz; acetone-d6) δ 149.0 (C), 147.4 (C), 141.0 (C), 130.6* (2 × CH), 127.7 (2 × CH), 124.4 (2 × CH), 124.0* (2 × CH), 78.6* (CH2), 68.4 (CH2) ppm (some peaks of the minor isomer could not be detected by 13C NMR due to their low intensity); IR (KBr) ν 3364 (O–H), 1599 (C
N), 1567 and 1380 (NO2) cm−1; MS m/z (%) relative intensity 225 (M+, 2), 147 (100), 102 (33), 89 (98); HRMS (ESI-TOF) calcd for C8H7N3NaO5 [M + Na]+ 248.0283, found 248.0282.
:
1, minor isomer marked*) δ 11.93 (s, 0.95H), 11.51* (s, 0.05H), 8.63 (t, J = 1.7 Hz, 1H of major and minor isomers), 8.32–8.29 (m, 1H of major and minor isomers), 8.24–8.21 (m, 1H of major and minor isomers), 7.77 (t, J = 8.0 Hz, 1H of major and minor isomers), 6.00 (s, 1.91H), 5.81* (s, 0.09H) ppm. 13C NMR (100 MHz; acetone-d6) δ 149.5 (C), 147.5 (C), 137.0 (C), 135.6* (CH), 132.9 (CH), 131.0 (CH), 130.6* (CH), 125.0* (CH), 124.8 (CH), 124.4* (CH), 121.5 (CH), 78.7* (CH2), 68.8 (CH2) ppm (some peaks of the minor isomer could not be detected by 13C NMR due to their low intensity); IR (KBr) ν 3314 (O–H), 1575 (C
N), 1533 and 1378 (NO2) cm−1; MS m/z (%) relative intensity 225 (M+, 1), 148 (100), 102 (56), 89 (41); HRMS (ESI-TOF) calcd for C8H7N3NaO5 [M + Na]+ 248.0283, found 248.0276.
N), 1554 and 1381 (NO2) cm−1; MS m/z (%) relative intensity 208 (M+, 6), 131 (90), 103 (76), 77 (100); HRMS (ESI-TOF) calcd for C9H8N2NaO4 [M + Na]+ 231.0382, found 231.0375.
N), 1574 and 1383 (NO2) cm−1; MS m/z (%) relative intensity 228 (M+, 3), 151 (100), 115 (44), 100 (30); HRMS (APCI-TOF) calcd for C9H10ClN2O3 [M + H]+ 229.0380, found 229.0375.
:
1, minor isomer marked*) δ 9.37 (br s, 1H of major and minor isomers), 7.42 (d, J = 8.1 Hz, 2H of major and minor isomers), 7.15 (d, J = 8.1 Hz, 2H of major and minor isomers), 5.56 (s, 1.83H), 5.31* (s, 0.17H), 2.30 (s, 3H of major and minor isomers) ppm. 13C NMR (100 MHz; CDCl3) δ 148.5 (C), 140.9 (C), 131.3* (C), 130.0 (C), 129.8 (2 × CH), 129.4* (2 × CH), 129.0* (C), 128.3* (2 × CH), 126.8* (C), 126.1 (2 × CH), 78.1* (CH2), 68.5 (CH2), 21.5* (CH3), 21.4 (CH3) ppm; IR (KBr) ν 3292 (O–H), 1611 (C
N), 1546 and 1377 (NO2) cm−1; HRMS (ESI-TOF) m/z calcd for C9H10N2NaO3 [M + Na]+ 217.0589, found 217.0595.
N), 1559 and 1380 (NO2) cm−1; HRMS (ESI-TOF) m/z calcd for C9H11N2O4 [M + H]+ 211.0719, found 211.0720.
:
1, minor isomer marked*) δ 9.27 (br s, 0.85H), 8.81* (br s, 0.15H), 7.57 (d, J = 8.5 Hz, 2H of major and minor isomers), 7.46 (d, J = 8.5 Hz, 2H of major and minor isomers), 5.66 (s, 1.69H), 5.41* (s, 0.31H), 1.33 (br s, 9H of major and minor isomers) ppm. 13C NMR (100 MHz; CDCl3) δ 153.9 (C), 148.4 (C), 130.0 (C), 128.1* (2 × CH), 126.1 (2 × CH), 125.9 (2 × CH), 125.7* (2 × CH), 78.1* (CH2), 68.4 (CH2), 34.9 (C), 31.1 (3 × CH3) ppm (some peaks of the minor isomer could not be detected by 13C NMR due to their low intensity); IR (KBr) ν 3300 (O–H), 1608 (C
N), 1558 and 1374 (NO2) cm−1; MS m/z (%) relative intensity 236 (M+, 6), 221 (52), 175 (35), 158 (100), 130 (40); HRMS (ESI-TOF) calcd for C12H16N2NaO3 [M + Na]+ 259.1059, found 259.1058.
:
1, minor isomer marked*) δ 11.35 (s, 1H of major and minor isomers), 7.63 (d, J = 8.3 Hz, 2H of major and minor isomers), 7.03 (d, J = 8.3 Hz, 2H of major and minor isomers), 5.66 (br s, 1.87H), 5.44* (br s, 0.13H), 2.14 (br s, 3H of major and minor isomers) ppm. 13C NMR (100 MHz; acetone-d6) δ 169.5 (C), 152.9 (C), 148.0 (C), 132.6 (C), 130.7* (2 × CH), 128.0 (2 × CH), 122.9 (2 × CH), 122.5* (2 × CH), 79.2* (CH2), 69.0 (CH2), 20.9 (CH3) ppm (some peaks of the minor isomer could not be detected by 13C NMR due to their low intensity); IR (KBr) ν 3278 (O–H), 1604 (C
N), 1570 and 1369 (NO2) cm−1; MS m/z (%) relative intensity 238 (M+, 7), 196 (21), 119 (31), 107 (100), 77 (25); HRMS (ESI-TOF) calcd for C10H10N2NaO5 [M + Na]+ 261.0487, found 261.0480.
N), 1559 and 1383 (NO2) cm−1; MS m/z (%) relative intensity 180 (M+, 3), 134 (11), 103 (100), 91 (65), 77 (42); HRMS (ESI-TOF) calcd for C8H8N2NaO3 [M + Na]+ 203.0433, found 203.0434.
:
1, minor isomer marked*) δ 9.61 (br s, 0.63H), 8.84* (br s, 0.37H), 8.01–7.88 (m, 3H of major and minor isomers), 7.68–7.37 (m, 4H of major and minor isomers), 5.63 (s, 1.26H), 5.46* (s, 0.74H) ppm. 13C NMR (100 MHz; CDCl3) δ 149.3* (C), 149.1 (C), 133.8 (C), 133.5* (C), 130.83 (C), 130.79* (C), 130.6 (CH), 130.5* (CH), 129.4 (C), 128.8 (CH), 128.7* (CH), 127.4* (CH), 127.3 (CH), 127.1* (CH), 126.9* (C), 126.57* (CH), 126.55 (CH), 125.4 (CH), 125.20 (CH), 125.18* (CH), 125.1* (CH), 124.5 (CH), 79.0* (CH2), 71.6 (CH2) ppm; IR (neat) ν 3273 (O–H), 1592 (C
N), 1558 and 1372 (NO2) cm−1; MS m/z (%) relative intensity 230 (M+, 14), 184 (31), 166 (100), 152 (47), 115 (19); HRMS (ESI-TOF) calcd for C12H10N2NaO3 [M + Na]+ 253.0589, found 253.0588.
:
1, minor isomer marked*) δ 11.29 (s, 0.70H), 10.86* (s, 0.30H), 7.64–7.39 (m, 5H of major and minor isomers), 6.10 (q, J = 6.9 Hz, 0.70H), 5.82* (q, J = 6.9 Hz, 0.30H), 1.86 (d, J = 6.9 Hz, 2.09H), 1.75* (d, J = 6.9 Hz, 0.91H) ppm. 13C NMR (100 MHz; acetone-d6) δ 153.3 (C), 152.3* (C), 134.8 (C), 132.1*(C), 130.2 (CH), 130.0* (CH), 129.4 (2 × CH), 129.1* (2 × CH), 129.0* (2 × CH), 127.4 (2 × CH), 86.2* (CH), 78.3 (CH), 17.1* (CH3), 15.4 (CH3) ppm; IR (KBr) ν 3237 (O–H), 1648 (C
N), 1546 and 1386 (NO2) cm−1; MS m/z (%) relative intensity 194 (M+, 2), 130 (26), 117 (70), 115 (100), 103 (32), 77 (65); HRMS (ESI-TOF) calcd for C9H10N2NaO3 [M + Na]+ 217.0589, found 217.0587.
N), 1547 and 1375 (NO2) cm−1; MS m/z (%) relative intensity 206 (M+, 1), 160 (10), 142 (23), 128 (36), 115 (100), 89 (31); HRMS (ESI-TOF) calcd for C10H10N2NaO3 [M + Na]+ 229.0589, found 229.0584.
:
1, minor isomer marked*) δ 9.29 (br s, 0.53H), 7.65 (d, J = 4.8 Hz, 0.51H), 7.48 (d, J = 3.9 Hz, 0.54H), 7.38* (d, J = 4.8 Hz, 0.49H), 7.28* (d, J = 3.9 Hz, 0.47H), 7.13 (dd, J = 4.8, 3.9 Hz, 0.54H), 7.07* (dd, J = 4.8, 3.9 Hz, 0.49H), 5.64 (s, 0.93H), 5.54 (s, 1H) (some peaks of the minor isomer could not be detected by 1H NMR due to their low intensity). 13C NMR (75 MHz; CDCl3) δ 144.3* (C), 142.4 (C), 136.6* (C), 132.3* (CH), 129.6 (C), 129.4 (CH), 128.6* (CH), 127.6 (CH), 127.4* (CH), 126.2 (CH), 77.4 (CH2), 68.0* (CH2); IR (KBr) ν 3265 (O–H), 1637 (C
N), 1557 and 1375 (NO2) cm−1; MS m/z (%) relative intensity 186 (M+, 11), 140 (14), 109 (37), 97 (100); HRMS (ESI-TOF) calcd for C6H6N2NaO3S [M + Na]+ 208.9997, found 208.9996.Footnote |
| † Electronic supplementary information (ESI) available. See DOI: 10.1039/c4ra11703d |
| This journal is © The Royal Society of Chemistry 2014 |